Published in Acta Ophthalmol on October 30, 2013
Spatial agreement between Goldmann visual field defects and fundus autofluorescence in patients with birdshot chorioretinopathy. J Ophthalmic Inflamm Infect (2016) 0.75
Analysis of autofluorescence pattern in birdshot chorioretinopathy. Graefes Arch Clin Exp Ophthalmol (2017) 0.75
Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care (2010) 3.29
Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration: the EXCITE study. Ophthalmology (2010) 3.22
Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments. Invest Ophthalmol Vis Sci (2009) 3.19
The challenge of comprehensively mapping children's health in a nation-wide health survey: design of the German KiGGS-Study. BMC Public Health (2008) 2.58
Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett (2007) 1.80
Classification of fundus autofluorescence patterns in early age-related macular disease. Invest Ophthalmol Vis Sci (2005) 1.76
Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma. Am J Ophthalmol (2006) 1.72
TREAT-AND-EXTEND REGIMENS WITH ANTI-VEGF AGENTS IN RETINAL DISEASES: A Literature Review and Consensus Recommendations. Retina (2015) 1.67
Is there a link between open-angle glaucoma and dementia? The Three-City-Alienor cohort. Ann Neurol (2013) 1.60
Differential targeting of GSH1 and GSH2 is achieved by multiple transcription initiation: implications for the compartmentation of glutathione biosynthesis in the Brassicaceae. Plant J (2005) 1.57
VEGF Trap-Eye for macular oedema secondary to central retinal vein occlusion: 6-month results of the phase III GALILEO study. Br J Ophthalmol (2013) 1.54
Quantitative analysis of fluorescence lifetime measurements of the macula using the fluorescence lifetime imaging ophthalmoscope in healthy subjects. Invest Ophthalmol Vis Sci (2014) 1.46
Morphologic changes in patients with geographic atrophy assessed with a novel spectral OCT-SLO combination. Invest Ophthalmol Vis Sci (2008) 1.42
Elaborate spatial patterning of cell-wall PME and PMEI at the pollen tube tip involves PMEI endocytosis, and reflects the distribution of esterified and de-esterified pectins. Plant J (2007) 1.34
Correlation between the area of increased autofluorescence surrounding geographic atrophy and disease progression in patients with AMD. Invest Ophthalmol Vis Sci (2006) 1.34
Structural insights into the target specificity of plant invertase and pectin methylesterase inhibitory proteins. Plant Cell (2004) 1.33
Microcystic macular degeneration from optic neuropathy. Brain (2012) 1.27
Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month MONT BLANC study results. Ophthalmology (2012) 1.26
Cytomegalovirus retinitis following intravitreal injection of triamcinolone: report of two cases. Acta Ophthalmol Scand (2007) 1.25
A role for pectin de-methylesterification in a developmentally regulated growth acceleration in dark-grown Arabidopsis hypocotyls. New Phytol (2010) 1.23
Effects of ranibizumab in patients with subfoveal choroidal neovascularization attributable to age-related macular degeneration. Am J Ophthalmol (2009) 1.23
Decreased visual function after patchy loss of retinal pigment epithelium induced by low-dose sodium iodate. Invest Ophthalmol Vis Sci (2009) 1.20
A randomized controlled trial of alleviated positioning after small macular hole surgery. Ophthalmology (2010) 1.19
Prevalence of refractive error in Europe: the European Eye Epidemiology (E(3)) Consortium. Eur J Epidemiol (2015) 1.18
Changes in fundus autofluorescence in patients with age-related maculopathy. Correlation to visual function: a prospective study. Graefes Arch Clin Exp Ophthalmol (2004) 1.17
The effects of a flexible visual acuity-driven ranibizumab treatment regimen in age-related macular degeneration: outcomes of a drug and disease model. Invest Ophthalmol Vis Sci (2009) 1.15
Diagnostic work-up of rectal bleeding in general practice. Br J Gen Pract (2005) 1.09
Ocular toxicity after intracameral injection of very high doses of cefuroxime during cataract surgery. J Cataract Refract Surg (2011) 1.09
Behavior of SD-OCT-detected hyperreflective foci in the retina of anti-VEGF-treated patients with diabetic macular edema. Invest Ophthalmol Vis Sci (2012) 1.07
Consensus structure elucidation combining GC/EI-MS, structure generation, and calculated properties. Anal Chem (2012) 1.03
Predictors of short-term visual outcome after anti-VEGF therapy of macular edema due to central retinal vein occlusion. Invest Ophthalmol Vis Sci (2011) 1.03
Genotypic influences on severity of exudative age-related macular degeneration. Invest Ophthalmol Vis Sci (2009) 1.03
[Treatment of Acute Central Retinal Artery Occlusion (CRAO) by Hyperbaric Oxygenation Therapy (HBO)--Pilot study with 21 patients]. Klin Monbl Augenheilkd (2002) 1.03
The glucocorticoid triamcinolone acetonide inhibits osmotic swelling of retinal glial cells via stimulation of endogenous adenosine signaling. J Pharmacol Exp Ther (2005) 1.01
Proprioception in total, hemi- and reverse shoulder arthroplasty in 3D motion analyses: a prospective study. Int Orthop (2008) 1.00
A new instrument for the quantification of macular pigment density: first results in patients with AMD and healthy subjects. Graefes Arch Clin Exp Ophthalmol (2002) 0.99
Laser photocoagulation for choroidal neovascular membrane associated with optic disc drusen. Acta Ophthalmol Scand (2004) 0.98
Ethnic differences in macular pigment density and distribution. Invest Ophthalmol Vis Sci (2007) 0.97
Distribution of amyloid precursor protein and amyloid-beta immunoreactivity in DBA/2J glaucomatous mouse retinas. Invest Ophthalmol Vis Sci (2007) 0.96
Fixation stability and macular light sensitivity in patients with diabetic maculopathy: a microperimetric study with a scanning laser ophthalmoscope. Ophthalmologica (2005) 0.96
High concentrations of plasma n3 fatty acids are associated with decreased risk for late age-related macular degeneration. J Nutr (2013) 0.95
Management of branch retinal vein occlusion with vitrectomy and arteriovenous adventitial sheathotomy, the possible role of surgical posterior vitreous detachment. Graefes Arch Clin Exp Ophthalmol (2003) 0.95
Selective staining by vital dyes of Müller glial cells in retinal wholemounts. Glia (2004) 0.94
German cancer statistics 2004. BMC Cancer (2010) 0.93
Different antivascular endothelial growth factor treatments and regimens and their outcomes in neovascular age-related macular degeneration: a literature review. Br J Ophthalmol (2013) 0.92
p16 expression differentiates high-risk gastrointestinal stromal tumor and predicts poor outcome. Neoplasia (2008) 0.92
Small dense particles in the retina observable by spectral-domain optical coherence tomography in age-related macular degeneration. Invest Ophthalmol Vis Sci (2010) 0.92
Blue-light versus green-light autofluorescence: lesion size of areas of geographic atrophy. Invest Ophthalmol Vis Sci (2011) 0.91
Database supported candidate search for metabolite identification. J Integr Bioinform (2011) 0.91
Changes in retinal gene expression in proliferative vitreoretinopathy: glial cell expression of HB-EGF. Mol Vis (2005) 0.91
Associations of complement factor H and smoking with early age-related macular degeneration: the ALIENOR study. Invest Ophthalmol Vis Sci (2011) 0.90
Extracellular invertase is involved in the regulation of clubroot disease in Arabidopsis thaliana. Mol Plant Pathol (2010) 0.90
Macular pigment density in healthy subjects quantified with a modified confocal scanning laser ophthalmoscope. Graefes Arch Clin Exp Ophthalmol (2003) 0.89
Long-term intraocular pressure changes in patients with neovascular age-related macular degeneration treated with ranibizumab. Ophthalmologica (2013) 0.89
External application of gametophyte-specific ZmPMEI1 induces pollen tube burst in maize. Plant Reprod (2013) 0.88
Transcriptomic analysis of human retinal detachment reveals both inflammatory response and photoreceptor death. PLoS One (2011) 0.88
Scleral buckling versus primary vitrectomy in rhegmatogenous retinal detachment study (SPR Study): recruitment list evaluation. Study report no. 2. Graefes Arch Clin Exp Ophthalmol (2006) 0.88
Angiographic findings in patients with exudative age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2002) 0.88
Long-term blood pressure and age-related macular degeneration: the ALIENOR study. Invest Ophthalmol Vis Sci (2013) 0.87
Macular pigment density in age-related maculopathy. Graefes Arch Clin Exp Ophthalmol (2004) 0.86
Dietary omega-3 fatty acids and the risk for age-related maculopathy: the Alienor Study. Invest Ophthalmol Vis Sci (2011) 0.86
Intraocular pressure changes following 20G pars-plana vitrectomy. Acta Ophthalmol (2011) 0.86
Association of macular pigment density with plasma ω-3 fatty acids: the PIMAVOSA study. Invest Ophthalmol Vis Sci (2012) 0.86
Impact of optic media opacities and image compression on quantitative analysis of optical coherence tomography. Invest Ophthalmol Vis Sci (2008) 0.85
Expression of HB-EGF by retinal pigment epithelial cells in vitreoretinal proliferative disease. Curr Eye Res (2006) 0.85
Diversity of aquaporin mRNA expressed by rat and human retinas. Neuroreport (2005) 0.84
Progression of age-related geographic atrophy: role of the fellow eye. Invest Ophthalmol Vis Sci (2011) 0.84
Association of HDL-related loci with age-related macular degeneration and plasma lutein and zeaxanthin: the Alienor study. PLoS One (2013) 0.84
Treatment of branch retinal vein occlusion induced macular edema with bevacizumab. BMC Ophthalmol (2008) 0.83
Complement Factor P in choroidal neovascular membranes of patients with age-related macular degeneration. Retina (2009) 0.82
Identification of P2Y receptor subtypes in human muller glial cells by physiology, single cell RT-PCR, and immunohistochemistry. Invest Ophthalmol Vis Sci (2005) 0.82
Outcomes following three-line vision loss during treatment of neovascular age-related macular degeneration: subgroup analyses from MARINA and ANCHOR. Br J Ophthalmol (2011) 0.82
R102G polymorphism of the C3 gene associated with exudative age-related macular degeneration in a French population. Mol Vis (2010) 0.82
Dry eye disease in French elderly subjects: the Alienor Study. Acta Ophthalmol (2013) 0.82
Simple and objective method for routine detection of the macular pigment xanthophyll. J Biomed Opt (2011) 0.81
Quantitative assessment of the long-term effect of photodynamic therapy in patients with pathologic myopia. Graefes Arch Clin Exp Ophthalmol (2005) 0.81
Risk factors for exudative age-related macular degeneration in a large French case-control study. Graefes Arch Clin Exp Ophthalmol (2013) 0.80
Fluorescence lifetime imaging in retinal artery occlusion. Invest Ophthalmol Vis Sci (2015) 0.80
No association between the T280M polymorphism of the CX3CR1 gene and exudative AMD. Exp Eye Res (2011) 0.80
Three-year results of visual outcome with disease activity-guided ranibizumab algorithm for the treatment of exudative age-related macular degeneration. Acta Ophthalmol (2012) 0.80
Can shoulder arthroplasty restore the range of motion in activities of daily living? A prospective 3D video motion analysis study. J Shoulder Elbow Surg (2010) 0.80
Intravitreal Ranibizumab in Daily Clinical Practice for Age-Related Macular Degeneration: Treatment of Exudative Age-Related Macular Degeneration in Real Life. Ophthalmologica (2015) 0.80
Macular pigment density at the site of altered fundus autofluorescence. Graefes Arch Clin Exp Ophthalmol (2010) 0.79
Complications after photodynamic therapy. Arch Ophthalmol (2005) 0.79
Effects of combination therapy with verteporfin photodynamic therapy and ranibizumab in patients with age-related macular degeneration. Acta Ophthalmol (2009) 0.79
RETINAL LAYER RESPONSE TO RANIBIZUMAB DURING TREATMENT OF DIABETIC MACULAR EDEMA: Thinner is Not Always Better. Retina (2016) 0.79
Oral Lutein Supplementation Enhances Macular Pigment Density and Contrast Sensitivity but Not in Combination With Polyunsaturated Fatty Acids. Invest Ophthalmol Vis Sci (2015) 0.79